InVivoMAb anti-mouse IL-10R (CD210)
References provided by Bioz:
Powered by Bioz
About InVivoMAb anti-mouse IL-10R (CD210)
The 1B1.3A monoclonal antibody reacts with mouse IL-10R (IL-10 receptor) also known as CD210. The IL-10R is a class II cytokine receptor and is expressed by a variety of cell types including thymocytes, T lymphocytes, B lymphocytes, NK cells, monocytes, and macrophages. Upon binding IL-10, IL-10R stimulation results in many pleiotropic, effects in immunoregulation and inflammation. IL-10R downregulates the expression of pro-inflammatory cytokines, MHC class II antigens, and co-stimulatory molecules on macrophages. It also enhances B lymphocyte survival, proliferation, and antibody production. IL-10R signaling can block NF-κB activity, and is involved in the regulation of the JAK-STAT signaling pathway. The 1B1.3A antibody is a neutralizing antibody and has been shown to block the binding of human IL-10, which cross-reacts with the mouse IL-10R. However, this clone does not recognize the human IL-10R.
InVivoMAb anti-mouse IL-10R (CD210) Specifications
Rat IgG1, κ
|Recommended Isotype Control(s)||
InVivoMAb rat IgG1 isotype control, anti-horseradish peroxidase(BE0088)
InVivoMAb rat IgG1 Isotype control, anti-trinitrophenol(BE0290)
|Recommended InVivoPure Dilution Buffer||InVivoPure pH 6.5T Dilution Buffer(IPT065)|
Recombinant ligand-binding domain of mouse IL-10R
0.2 μM filtered
Purified from tissue culture supernatant in an animal free facility
The antibody solution should be stored undiluted at 4°C, and protected from prolonged exposure to light. Do not freeze.